Dr. Antreas D Mesrobian

DDS | Dentist



  
  146 Biesterfield Rd, Elk Grove Village
  Illinois, 60007-3657

  847-437-6500    847-437-6720 Maps & Directions
Dr. Antreas D Mesrobian is a Elk Grove Village, Illinois based Dentist who is specialized in General Practice Dentistry. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. His current practice location is 146 Biesterfield Rd, Elk Grove Village. Patients can reach him at 847-437-6500.
Dr. Antreas D Mesrobian is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Antreas D Mesrobian speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Antreas D Mesrobian
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:No
Practice Address:146 Biesterfield Rd, Elk Grove Village,
Illinois, 60007-3657
Phone:847-437-6500
Fax:847-437-6720
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1699843318
NPI Enumeration Date: 01 Dec, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 1775 Aspen Dr,
Lake Forest, Illinois
Zip: 60045-4617
Phone Number: 847-302-4545
Fax Number: 847-437-6720
Patients can reach Dr. Antreas D Mesrobian at 146 Biesterfield Rd, Elk Grove Village, Illinois or can call to book an appointment on 847-437-6500. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: